O Brien Greene & Co. Inc lessened its position in Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT – Free Report) by 52.7% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 29,200 shares of the oil and gas company’s stock after selling 32,500 shares during the period. O Brien Greene & Co. Inc’s holdings in Calumet Specialty Products Partners were worth $469,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also made changes to their positions in the company. ICA Group Wealth Management LLC acquired a new stake in shares of Calumet Specialty Products Partners in the 4th quarter valued at approximately $116,000. Future Financial Wealth Managment LLC acquired a new position in shares of Calumet Specialty Products Partners during the 1st quarter worth $119,000. Wedbush Securities Inc. purchased a new position in shares of Calumet Specialty Products Partners in the 2nd quarter valued at about $169,000. Deuterium Capital Management LLC purchased a new stake in Calumet Specialty Products Partners during the first quarter worth about $159,000. Finally, Mcintyre Freedman & Flynn Investment Advisers Inc. acquired a new stake in shares of Calumet Specialty Products Partners during the 1st quarter valued at approximately $171,000. 34.41% of the stock is currently owned by institutional investors and hedge funds.
Calumet Specialty Products Partners Stock Performance
CLMT stock opened at $18.29 on Wednesday. Calumet Specialty Products Partners, L.P. has a one year low of $9.97 and a one year high of $21.19. The stock has a market capitalization of $1.47 billion, a P/E ratio of -261.29 and a beta of 1.92. The company has a 50 day moving average price of $15.72 and a two-hundred day moving average price of $15.62.
Analyst Ratings Changes
Several research analysts have recently issued reports on the company. TD Cowen cut their price target on Calumet Specialty Products Partners from $20.00 to $18.00 and set a “buy” rating for the company in a research note on Monday, August 12th. The Goldman Sachs Group lowered their target price on Calumet Specialty Products Partners from $17.00 to $15.00 and set a “buy” rating on the stock in a report on Monday, August 5th. HC Wainwright reissued a “buy” rating and issued a $25.00 price target on shares of Calumet Specialty Products Partners in a report on Monday, August 12th. Finally, StockNews.com started coverage on Calumet Specialty Products Partners in a research note on Friday, September 13th. They set a “hold” rating on the stock. One analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $19.33.
Read Our Latest Research Report on Calumet Specialty Products Partners
About Calumet Specialty Products Partners
Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Performance brands; Montana/Renewables; and Corporate segments.
Featured Articles
- Five stocks we like better than Calumet Specialty Products Partners
- With Risk Tolerance, One Size Does Not Fit All
- Seize the Opportunity: Beyond Meat’s New Steak Could Spark Growth
- What is the Dow Jones Industrial Average (DJIA)?
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Using the MarketBeat Dividend Tax Calculator
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
Receive News & Ratings for Calumet Specialty Products Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners and related companies with MarketBeat.com's FREE daily email newsletter.